Was the Credo Technology (CRDO) CFO’s share sale under a Rule 10b5-1 plan?

Yes. The Form 4 states the sales were effected under a Rule 10b5-1 trading plan adopted by Daniel W. Fleming on January 12, 2026. Such pre-arranged plans schedule trades in advance, reducing the significance of trade timing information.

Credo Technology CFO sells shares under 10b5-1 plan

Q: What did Credo Technology (CRDO) CFO Daniel W. Fleming report in this Form 4?

Daniel W. Fleming reported selling 7,580 Ordinary Shares of Credo Technology Group Holding Ltd in open-market transactions on July 8, 2026. These sales were made under a Rule 10b5-1 trading plan and he retained more than 500,000 shares afterward.

Q: How many Credo Technology (CRDO) shares did the CFO sell and at what prices?

The CFO sold 7,580 Ordinary Shares of CRDO in multiple trades at prices between $240.50 and $249.99 per share. Each Form 4 line reflects a weighted average sale price for trades executed within specified price ranges.

Q: What type of transactions did the Credo Technology (CRDO) CFO report?

All reported transactions were open-market sales of Ordinary Shares, coded “S” on the Form 4. There were 10 separate sale entries, with no option exercises, gifts, or tax-withholding dispositions reported for this date in the filing’s transaction summary.

Q: Did the Credo Technology (CRDO) CFO sell or buy shares in this Form 4?

He only sold shares. The transaction summary shows 7,580 shares sold, 0 shares purchased, and a resulting net-sell position for the reported date. All transactions involved non-derivative Ordinary Shares held directly by the reporting person.

Credo Technology Group Holding Ltd Chief Financial Officer Daniel W. Fleming reported open-market sales of 7,580 Ordinary Shares of CRDO on July 8, 2026.

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Credo Technology Group Holding Ltd Chief Financial Officer Daniel W. Fleming reported open-market sales of 7,580 Ordinary Shares of CRDO on July 8, 2026. The trades were executed at prices ranging from $240.50 to $249.99 under a pre-arranged Rule 10b5-1 trading plan adopted on January 12, 2026. Following these transactions, he continued to hold more than 500,000 Ordinary Shares directly.

Filing Explained

The material holder-level change is an executed July 8 sale sequence ending with 504,708 directly held shares.

This Form 4, filed on July 13, 2026, reports that Daniel W. Fleming, Credo’s CFO and a 10% owner, executed sales of ordinary shares on July 8, 2026.

For existing common holders, the structural change disclosed here is the reporting person’s direct ownership position: the table ends at 504,708 shares after the reported sales.

The filing says the sales were effected under a Rule 10b5-1 trading plan adopted on January 12, 2026; such a plan is written in advance and executes trades on a schedule or formula, while its adoption date does not state the reasons for individual trades.

The prices shown are weighted averages for multiple trades, with the filing providing transaction-specific price ranges and stating that fuller trade details can be provided on request.

Insider Trade Summary 10b5-1

Net Seller: 7,580 shares

Net Sell 10 txns

Insider Fleming Daniel W.

Role Chief Financial Officer

Sold 7,580 shs ($1.86M)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares ^{F1, F2}	461	$240.6083	$111K
Sale	Ordinary Shares ^{F1, F3}	372	$241.8998	$90K
Sale	Ordinary Shares ^{F1, F4}	764	$243.1243	$186K
Sale	Ordinary Shares ^{F1, F5}	1,136	$244.0577	$277K
Sale	Ordinary Shares ^{F1, F6}	893	$245.0078	$219K
Sale	Ordinary Shares ^{F1, F7}	623	$246.1019	$153K
Sale	Ordinary Shares ^{F1, F8}	107	$247.4795	$26K
Sale	Ordinary Shares ^{F1, F9}	1,593	$247.8733	$395K
Sale	Ordinary Shares ^{F1, F10}	1,237	$249.043	$308K
Sale	Ordinary Shares ^{F1, F11}	394	$249.6092	$98K

Holdings After Transaction: Ordinary Shares — 504,708 shares (Direct)

Footnotes (11)

F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 12, 2026.
F2. This transaction was executed in multiple trades at prices ranging from $240.50 to $241.31. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3. This transaction was executed in multiple trades at prices ranging from $241.51 to $242.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4. This transaction was executed in multiple trades at prices ranging from $243.05 to $243.31. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5. This transaction was executed in multiple trades at prices ranging from $243.56 to $244.45. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6. This transaction was executed in multiple trades at prices ranging from $244.56 to $245.44. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7. This transaction was executed in multiple trades at prices ranging from $245.65 to $246.27. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F8. This transaction was executed in multiple trades at prices ranging from $247.33 to $247.49. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F9. This transaction was executed in multiple trades at prices ranging from $247.54 to $248.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F10. This transaction was executed in multiple trades at prices ranging from $248.55 to $249.49. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F11. This transaction was executed in multiple trades at prices ranging from $249.51 to $249.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Key Figures

Shares Sold: 7,580 shares Sale Price Range: $240.50–$249.99 per share Post-transaction Holdings (approx.): More than 500,000 shares +2 more

5 metrics

Shares Sold 7,580 shares Total Ordinary Shares sold by the CFO on July 8, 2026

Sale Price Range $240.50–$249.99 per share Price ranges for multiple open-market trades on July 8, 2026

Post-transaction Holdings (approx.) More than 500,000 shares Direct Ordinary Share holdings remaining after reported sales

Number of Sale Transactions 10 transactions Non-derivative open-market sale entries reported for July 8, 2026

10b5-1 Plan Adoption Date January 12, 2026 Date the CFO adopted the Rule 10b5-1 trading plan

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, Ordinary Shares, open-market sale

4 terms

Rule 10b5-1 trading plan regulatory

"The sales reported ... were effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"The price reported above reflects the weighted average sale price"

Ordinary Shares financial

"security_title: Ordinary Shares"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

open-market sale financial

"transaction_action: open-market sale"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

FAQ

What did Credo Technology (CRDO) CFO Daniel W. Fleming report in this Form 4?

Daniel W. Fleming reported selling 7,580 Ordinary Shares of Credo Technology Group Holding Ltd in open-market transactions on July 8, 2026. These sales were made under a Rule 10b5-1 trading plan and he retained more than 500,000 shares afterward.

How many Credo Technology (CRDO) shares did the CFO sell and at what prices?

The CFO sold 7,580 Ordinary Shares of CRDO in multiple trades at prices between $240.50 and $249.99 per share. Each Form 4 line reflects a weighted average sale price for trades executed within specified price ranges.

How many Credo Technology (CRDO) shares does the CFO still own after these sales?

After these reported sales, Daniel W. Fleming continued to hold more than 500,000 Ordinary Shares of Credo Technology Group Holding Ltd directly. The Form 4 ownership entries each show post-transaction holdings above this level for his direct share position.

What type of transactions did the Credo Technology (CRDO) CFO report?

All reported transactions were open-market sales of Ordinary Shares, coded “S” on the Form 4. There were 10 separate sale entries, with no option exercises, gifts, or tax-withholding dispositions reported for this date in the filing’s transaction summary.

Did the Credo Technology (CRDO) CFO sell or buy shares in this Form 4?

He only sold shares. The transaction summary shows 7,580 shares sold, 0 shares purchased, and a resulting net-sell position for the reported date. All transactions involved non-derivative Ordinary Shares held directly by the reporting person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 07/13/2026 - 03:58 PM Accepted by SEC EDGAR 07/13/2026 - 03:58 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fleming Daniel W.

(Last)

(First)

(Middle)

110 RIO ROBLES

(Street)

SAN JOSE

CALIFORNIA

95134

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Credo Technology Group Holding Ltd [ CRDO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	07/08/2026		S⁽¹⁾		461	D	$240.6083⁽²⁾	511,827	D
Ordinary Shares	07/08/2026		S⁽¹⁾		372	D	$241.8998⁽³⁾	511,455	D
Ordinary Shares	07/08/2026		S⁽¹⁾		764	D	$243.1243⁽⁴⁾	510,691	D
Ordinary Shares	07/08/2026		S⁽¹⁾		1,136	D	$244.0577⁽⁵⁾	509,555	D
Ordinary Shares	07/08/2026		S⁽¹⁾		893	D	$245.0078⁽⁶⁾	508,662	D
Ordinary Shares	07/08/2026		S⁽¹⁾		623	D	$246.1019⁽⁷⁾	508,039	D
Ordinary Shares	07/08/2026		S⁽¹⁾		107	D	$247.4795⁽⁸⁾	507,932	D
Ordinary Shares	07/08/2026		S⁽¹⁾		1,593	D	$247.8733⁽⁹⁾	506,339	D
Ordinary Shares	07/08/2026		S⁽¹⁾		1,237	D	$249.043⁽¹⁰⁾	505,102	D
Ordinary Shares	07/08/2026		S⁽¹⁾		394	D	$249.6092⁽¹¹⁾	504,708	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 12, 2026.

2. This transaction was executed in multiple trades at prices ranging from $240.50 to $241.31. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

3. This transaction was executed in multiple trades at prices ranging from $241.51 to $242.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

4. This transaction was executed in multiple trades at prices ranging from $243.05 to $243.31. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

5. This transaction was executed in multiple trades at prices ranging from $243.56 to $244.45. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

6. This transaction was executed in multiple trades at prices ranging from $244.56 to $245.44. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

7. This transaction was executed in multiple trades at prices ranging from $245.65 to $246.27. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

8. This transaction was executed in multiple trades at prices ranging from $247.33 to $247.49. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

9. This transaction was executed in multiple trades at prices ranging from $247.54 to $248.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

10. This transaction was executed in multiple trades at prices ranging from $248.55 to $249.49. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

11. This transaction was executed in multiple trades at prices ranging from $249.51 to $249.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

	/s/ James Laufman, attorney-in-fact	07/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

Credo Technology CFO sells shares under 10b5-1 plan

Rhea-AI Filing Summary

Positive

Negative